The Role of Mammography in Male Patients With Breast Symptoms

Hines, Stephanie L.; Yasrebi, Mona; Tan, Winston; Perez, Edith A.; DePeri, Elizabeth R.

doi:10.4065/82.3.297

Cited by 29 publications

(40 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although mammography is recommended for the surveillance and management of males at increased risk for MBC (46), its role in males with no apparent risk factors is less clear. The majority of breast symptoms in males are caused by benign abnormalities such as gynecomastia (49). The diagnostic challenge facing physicians is to correctly separate the small number of patients with malignant disease from the greater number with benign disease (50).…”

Section: Screening and Diagnosis Of Mbcmentioning

confidence: 99%

“…This task can be more difficult when there is no family history of breast cancer and no other risk factors for MBC, such as hormonal or occupational exposure. Several retrospective studies have found that a thorough clinical evaluation, including physical examination and fine-needle aspiration or core biopsy, is effective at distinguishing breast cancer from benign disease, and that mammographic data add little diagnostic information (49,(51)(52)(53). Others argue that mammography adds accuracy to the evaluation of breast symptoms (50).…”

Section: Screening and Diagnosis Of Mbcmentioning

confidence: 99%

See 1 more Smart Citation

Male breast cancer: Risk factors, diagnosis, and management (Review)

Taber¹

2010

Oncol Rep

View full text Add to dashboard Cite

Abstract. Male breast cancer (MBC) is extremely rare, with an incidence in the general US population of <1%. It tends to be diagnosed at later stages than breast cancer in females, likely because of low awareness on the part of the patient and low suspicion by the physician. Risk factors include genetic predisposition, alterations to the estrogen-testosterone ratio, radiation exposure, and occupational hazards. Because of the rarity of MBC, mammography in men is more often utilized as a diagnostic tool to evaluate breast symptoms rather than as a tool for widespread screening. While clinical breast examinations are effective at evaluating breast symptoms, mammography also may be beneficial in separating malignant from benign breast disease. This study reviews MBC and its risk factors, recommendations for screening and diagnosis, the roles of mammography and genetic testing in surveillance, and management of patients with MBC. Heightened awareness of the increased risk in certain men by both physicians and patients, and adherence to guidelines recommended for the surveillance of men at increased risk, may result in earlier detection.

show abstract

Section: Screening and Diagnosis Of Mbcmentioning

confidence: 99%

Section: Screening and Diagnosis Of Mbcmentioning

confidence: 99%

Male breast cancer: Risk factors, diagnosis, and management (Review)

Taber¹

2010

Oncol Rep

View full text Add to dashboard Cite

show abstract

“…In a study by Hines, after evaluating 212 mammographies the authors found only 4% suspicious images of which only 1% were cancers authenticated by biopsy [33]. The authors conclude that imagery screening of male breast is unnecessary and the diagnosis Z. Sonia et al…”

Section: /17mentioning

confidence: 99%

Male Breast Cancer: Case Studies and Literature Review

Zaied¹,

Khechine²,

Abbess³

et al. 2017

OALib

View full text Add to dashboard Cite

Male breast cancer is a rare disease. In Tunisia, it represents 1% of all breast cancers and 1.6% of Male neoplasia. This work is a retrospective study about 5 male patients with breast cancer, treated in the department of medical oncology at Fattouma Bourguiba University Hospital of Monastir (Tunisia) during a period of 3 years from March 2013 to March 2016. Results showed that: invasive ductual carcinoma was the histological type found in all cases; the Her 2 neu was not overexpressed in all cases; hormone receptors were positive in all patients. Two patients had a locally advanced disease. Two patients were diagnosed with metastatic disease; pulmonary and bone metastases. Three patients who were diagnosed with no metastatic disease have had a mastectomy with Axillary lymph node dissection. Adjuvant chemotherapy was administered in two patients. Loco regional radiotherapy was performed in three patients. Tamoxifen-based hormone therapy was administered in three patients. Two patients were treated with palliative chemotherapy. One patient received two lines of chemotherapy with a global survival of 16 months, while the other received only one line of palliative chemotherapy with a global survival of 2 months. One patient received palliative hormone therapy type Tamoxifen with progression free survival of 7 months. Three patients who received curative treatments are in remission of their disease. To conclude male breast cancer is a rare disease with multiple and varied risk factors. It is similar in its clinical, histological and prognostic characteristics to breast cancer in women but also has different characteristics.

show abstract

“…Opioids can be used safely to relieve pain and dyspnea, even in those with advanced liver disease (as well as advanced renal, pulmonary, and cardiac disease), and are preferred to nonsteroidal anti-inflammatory agents or other drugs, especially for moderate to severe pain. 5,8 In our diverse and varied practices, we routinely use low doses of opiates such as intravenous fentanyl (with its short half-life) or oral or parenteral hydromorphone (which has less hepatic clearance than morphine) and believe that this can be done safely. The clearance of these drugs is reduced in patients with liver failure; thus, the initial dose may need to be lower, the interval between the doses may need to be increased, and such patients will need to be assessed on a regular basis.…”

Section: Safe Use Of Opioids To Manage Pain In Patients With Cirrhosismentioning

confidence: 99%

“…Medically appropriate pain management to improve function and quality of life is acceptable for patients before they undergo transplant. [2][3][4] For those unsuitable for transplant (up to 85% of patients), palliative care 5,6 and occasionally hospice 7 are appropriate for many. Opioids can be used safely to relieve pain and dyspnea, even in those with advanced liver disease (as well as advanced renal, pulmonary, and cardiac disease), and are preferred to nonsteroidal anti-inflammatory agents or other drugs, especially for moderate to severe pain.…”

Section: Safe Use Of Opioids To Manage Pain In Patients With Cirrhosismentioning

confidence: 99%